Grateful to have such a thriving community of young colleagues worldwide and from so diverse backgrounds in transplant and cellular therapy🙏

Thanks to all members and newcomers, we aim to move things forward with vision in education, training and inclusion The EBMT and beyond.

Couldnt be prouder to have Claire Horgan as co chair of The EBMT Trainee Committee 🙏❤️🙏

An extraordinary partner, pediatrician, scientist and mother!

Thank you for 3 amazing years with @TheEBMT !

1st Workshop #Vexas 🤳 Retour en images sur ce bel événement qui aura réuni plus de 100 participants de 19 pays différents 🤩👏 Bravo à la Vexas Family ! #maladiesrares #fsmr ⤵️

A look back at the first workshop on #VEXAS syndrome! > 100 participants from 19 countries came in Paris. Thanks to the support of Filière de santé FAI²R. Benjamin Terrier Arsene Mekinian Peter Grayson Marcela Ferrada Kosmider olivier _ERNRITA Rim Bourguiba Ciprian Jurcut

TP53 mutation screening for patients at risk of myeloid malignancy | Leukemia ⁦Devdeep Mukhopadhyay⁩ ⁦⁦⁦Laura Dillon, PhD, FACMG⁩ nature.com/articles/s4137…

1st Workshop #Vexas 🎬 Clap de fin pour cette exceptionnelle collaboration 🤝 Un grand merci à toutes et tous pour votre participation et la qualité des échanges, vous avez fait de ce premier événement international dédié au VEXAS, une véritable réussite ! 👏 #maladiesrares ⤵️

📍 1st Workshop #Vexas c'est en ce moment à Paris ! Heureux d'accueillir David BECK, Peter GRAYSON et Marcela FERRADA, découvreurs du Syndrome Vexas. La filière FAI²R est honorée d'avoir contribué à l'aboutissement de ce premier événement international #fsmr #maladiesrares ⤵️

In conclusion👇the new FISH MM risk Myeloma Patients Europe International Myeloma Foundation Myeloma Patients Europe Rahul Banerjee, MD, FACP

In the issue, best practice recommendations from EBMT_Cellular_Therapy @TheEBMT on donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies #bmtsm #hemonc thelancet.com/journals/lanha…

Fresh off the press in The Lancet Haematology: DLI after allo-HCT - best practice recommendations on behalf of EBMT_Cellular_Therapy. Honored to be part of this great effort
Annalisa Ruggeri
Mette Hazenberg Jurgen Kuball sciencedirect.com/science/articl…

What treasures are kept inside the Vatican?

Some of mankind's most precious artifacts have been living there for centuries.

But they're nothing compared to what's underneath the Vatican... (thread) 🧵

Excited to see our NIH NHLBI NIAMS Mayo Clinic Comprehensive Cancer Center collaboration looking at #VTE in #VEXAS syndrome out in this issue of Blood Journal! Over 40% of patients had a VTE. yael kusne MD PhD Atefeh Ghorbanzadeh Bhavisha Patel ashpublications.org/blood/article-…

📍 1st Workshop #Vexas 23-24 mai 2024 à Paris 👀 Retour sur la suite des interventions de cette première journée réussie autour du Syndrome Vexas 👏 On se retrouve demain pour la deuxième journée ! ➕ Infos : fai2r.org/actualites/wor… #fsmr #maladiesrares ⤵️

Carmelo Gurnari discusses The EBMT registry data for #HSCT in #VEXAS ; primarily hematologic phenotype.

First international Vexas congrès in Paris
Vexas like what is it
By Sophie Georgin-Lavialle

Let’s go to the first #VEXAS international workshop in Paris fai2r.org/actualites/wor…

First international Vexas congrès in Paris
Infections In Vexas
By Jérôme Hadjadj
Jerome HADJADJ

First international VeXas congrès in Paris
Starting Wirth great talk by David Beck discovered UBA 1 mutation

The 1st International VEXAS workshop is on!!! Great Day1 Merce Feu Peter Grayson David Beck explain the history of the discovery of VEXAS!
Kudos to Sophie Georgin-Lavialle and Arsene Mekinian for organizing this in beautiful Paris! Hematology, Rheumatology and many more disciplines united!

First international VEXAS workshop beginning today in Paris. In presence of David Beck, Peter Grayson Marcela Ferrada
Thanks to our academic sponsor #fai2r .